Qiaomei He

机构：Shanghai Jiao Tong University, Shanghai First People's Hospital

发表论文 12 篇 · 总被引 119 次 · h-index 6

代表论文

• Circular mRNA-based TCR-T offers a safe and effective therapeutic strategy for treatment of cytomegalovirus infection (2023 · Molecular Therapy · 被引 32)
• Dissecting causal links between gut microbiota, inflammatory cytokines, and DLBCL: a Mendelian randomization study (2024 · Blood Advances · 被引 29)
• The nuclear receptor corepressor NCoR1 regulates hematopoiesis and leukemogenesis in vivo (2019 · Blood Advances · 被引 19)
• Preventive and Therapeutic Effects of a Novel JAK Inhibitor SHR0302 in Acute Graft-Versus-Host Disease (2021 · Cell Transplantation · 被引 15)
• Low-Dose Anti-Thymocyte Globulin Plus Low-Dose Posttransplant Cyclophosphamide as an Effective Regimen for Prophylaxis of Graft Versus Host Disease After Haploidentical Peripheral Blood Stem Cell Transplantation With Maternal/Collateral Related Donors (2022 · Cell Transplantation · 被引 14)
• A Novel JAK1 Inhibitor SHR0302 Combined With Prednisone for First-Line Treatment of Chronic Graft-Versus-Host Disease: A Phase I Clinical Trial (2024 · Cell Transplantation · 被引 8)